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MECHMISMS -ÛE CANINE ENDOTOXIN SHOCK; MODIFICATION 
OF THE SHOCK RESPONSE BY SALICYLATES
CHAPTER I 
INTRODUCTION
Endotoxin and its toxic manifestations in a wide variety of ani­
mals have been the subject of a vast number of scientific publications.
The devotion of numerous pages of literature to the subject of endotoxins 
is well justified in light of the fact that these toxic substances create 
critical and often lethal clinical situations in human patients (Altemeier, 
1967). This dissertation attempts first to review pertinent scientific 
literature and second to elucidate some of the evasive mechanisms of 
action of the endotoxins.
All mammalian species studied respond to intravenous endotoxin 
administration with severe arterial hypotension (Gilbert, 1960). Endotox­
in-shocked animals succumb to lethal doses of endotoxin ^y progressive 
failure of the circulation, although the precise mechanisms responsible 
have not been clearly defined (Zweifach, 1965). Endotoxin shock is gen­
erally described as a circulatory phenomenon although a variety of nervous, 
endocrine and metabolic processes have been implicated (Visscher, 1958).
Chemistry of the Endotoxin Complex
Endotoxin is the term commonly employed to designate a lipid-
1
2polysaccharide-protein complex existing in the cell wall of Gram-negative 
bacteria. From structural analyses and biosynthetic schemes it has been 
shown that the lipopolysaccharides are long-chain phosphorous-containing 
heteropolymers constituted of a lipid covalently linked to a core poly­
saccharide to which are attached serologically different oligosaccharide 
units (Luderitz ^  £l•» 1958). Because lipopolysaccharides are found in 
the cell wall of the Gram-negative organisms, they are also referred to 
as somatic antigens. Endotoxin is resistant to trypsin and high temper­
atures yet labile to mild acid hydrolysis.
One of the first extractions of the lipopolysaccharide moiety 
from the bacterial cell wall was that of Boivin and co-workers in 1935. 
They utilized trichloroacetic acid to extract the toxin from intact cells. 
Bacteria from 24-hour cultures were washed and suspended in distilled 
water to a concentration of 200 mg/ml. An equal volume of 0.5N trichloro­
acetic acid was added and the bacteria were extracted for 3 hours at low 
temperatures. The bacterial cells, morphologically intact and retaining 
their staining characteristics, were removed by centrifugation. The tox­
icity which remained in the supernatant was precipitated by 4 to 5 volumes 
of alcohol or acetone. The precipitate represented about 5 per cent of 
the dry weight of the bacteria but the yield could be increased to about 
10 per cent if the organisms were digested with trypsin prior to extrac­
tion. About 0.1 mg of the precipitate yield resulted in the death of a 
20 gm mouse following intraperitoneal injection.
Of the components of the endotoxin substance, the activity of the 
lipid fraction seems to be the most controversial. Gilbert (1960) and 
Luderitz and collaborators (1958) suggest that the lipid is of the utmost
3>1
importance in production of toxic manifestations. Luderitz and co-workers 
(1968) were able to dissociate the lipopolysaccharide complex into an in­
active polysaccharide and an active 'lipid A' which retained many toxic 
properties when recombined with a natural or artificial protein carrier. 
Contrary to the previous results, Tal and Olitsky (1948) and Ribi and co­
workers (1961) find no evidence that the lipopolysaccharide complex dif­
fers quantitatively and qualitatively from one species of Gram-negative 
bacteria to another. The suggestion was made that these qualitative and 
quantitative differences in lipid components might influence certain bio­
logical activities when bound to the polysaccharide of the lipopolysac­
charide unit (Kasai, 1966). The discrepancy between reports which eval­
uated the toxic properties of the lipid fraction might be attributed to 
use of different extraction procedures.
Most investigators currently feel that the major endotoxic act­
ivity cannot be attributed to the lipid component and is due to the poly­
saccharide (Raskova and Vaneœk, 1964; Burrows, 1951). The polysaccharide, 
which may or may not be esterified, functions as a haptene and is respon­
sible for the immunological specificity of the toxic complex (Burrows,
1951; Staub, 1964). Ribi and co-workers have presented evidence that the 
polysaccharide moiety is largely responsible for both the toxic and anti­
genic effects of endotoxin from Salmonella enteriditis (Ribi ^  a^., 1960). 
Still another communication reports that lipopolysaccharide modified by 
periodate treatment, resulting in oxidation of the polysaccharide fraction, 
loses its antigenic specificity and many of its toxic properties though 
its pyrogenicity is retained (Neter e_t ai^ ., 1956). This apparent dissoc­
iation of biological effects induced by chemical modification of the
4molecule suggests that there may be specific reactive groupings respon-' 
slble for various toxic properties (Atkins, 1960). Alaupovlc et al.
(1968) Implicate a macromolecular fatty acld-carbohydrate complex of un­
known structure and size as the chemical requirement for elicitation of 
the characteristic hemodynamic response to endotoxin.
Hemodynamic Response to Endotoxin
The appearance of a shock-llke state In association with an Infec­
tion was first described by Laennec In 1831. In the late nineteenth cen­
tury, Boise (1897) contrasted special features of septic shock to vascu­
lar collapse following hemorrhage. Since the middle 1950's, there has 
been considerable Interest In the special type of bacterial shock due to 
Gram-negative enteric bacteria, first described as a clinical entity by 
Walsbren (1951) and by Borden and Hall (1951). These historical scientif­
ic communications established systemic hypotension as a characteristic 
feature of the endotoxic condition while also dividing the syndrome Into 
two distinct clinical pictures: one being the toxic state produced by
the Invading bacteria and the second being the hypotensive state Initiat­
ed by the effects of the endotoxin. Walsbren (1951) also noted that the 
clinical syndrome produced by the Gram-negative bacteria was essentially 
the same regardless of the bacterial species Involved. A subsequent re­
view of clinical shock associated with Gram-negative bacteremia advocated 
the use of norepinephrine to support blood pressure and antibiotics to 
combat the underlying Infection (Wise al., 1952).
Since the first clinical observations of the Gram-negative septic 
shock state were made at the University of Minnesota (Walsbren, 1951; 
Borden and Hall, 1951; Wise et al,, 1952), It Is not surprising that many
5of the early research investigations of shock were also carried out there. 
It soon became common practice to evaluate septic shock by administering 
endotoxin, prepared according to the method of Boivin, to the anesthetized 
laboratory dog. Therefore, the canine hemodynamic reaction following in­
jection of endotoxin has been extensively studied during the past few 
years. MacLean and Weil (l956) at the University of Minnesota, documented 
the pattern of shock, elicited by injection of Escherichia coli endotoxin, 
as characterized by an almost immediate and precipitous decline in system­
ic arterial blood pressure with a concomitant rise in portal venous pres­
sure. Subsequently, numerous investigations corroborated these early re­
ports (MacLean and Weil, 1956; MacLean _et £l., 1956; Weil , 1956a;
Lillehei and MacLean, 1958). These hemodynamic alterations were evident 
within the first two minutes after the toxin was given. At approximately 
15 to 20 minutes postendotoxin, the portal venous pressure declined to 
near control levels accompanied by a partial recovery of systemic blood 
pressure. These findings together with pathological changes of congestion 
and hemorrhage in the mesenteric vascular bed made it appear that shock 
was at least partially due to trapping of blood in the hepato-splanchnic 
vascular bed (MacLean and Weil, 1956; Weil e^ £l., 1956a).
The liver soon became suspect as the site of sequestration of 
blood. The immediate systemic hypotensive response to endotoxin was avoid­
ed by excluding the liver from the circulation either by hepatectomy or 
devascularization (MacLean and Weil, 1956). Subsequent studies of in situ 
perfused canine livers revealed that following injection of coli endo­
toxin, there was a prompt rise in liver weight. The perfused liver also 
responded with an increase in vascular resistance (Hinshaw et_ aJ^ ., 1966).
6The combination of increased weight and vascular resistance results from 
hepatic venous constriction (Weil e^ al., 1956a). This is a transient con­
striction of the hepatic veins and is usually concluded from 5 to 25 min­
utes after endotoxin administration.
In situ perfusion studies of the canine intestine revealed small 
early rises in intestinal weight (MacLean a]^ ., 1956). It is probable 
that the early and simultaneous increases in liver and intestinal weights 
represent a significant pooling of blood and may well be the major repos­
itory of the venous blood in the canine species. Comparison of hepatic 
and intestinal weight responses to endotoxin reveals that the liver soon 
returns to steady control levels while the intestine exhibits a contin­
uous yet slow and steady gain in weight. After 60 minutes, this rise in 
intestinal weight represents a significant amount of sequestration of 
blood. The increase in intestinal weight is probably due in large part
to an increase in interstitial fluid (Gilbert, 1960) as suggested by re-
131ports that after endotoxin there is an accumulation of I tagged albu­
min in the intestinal wall which corresponds to a 7 to 22 per cent increase 
in plasma content (Aust ^  £l., 1957). The later phase of weight gain 
presumably cannot be attributed to increased portal pressure because 
portal pressure has returned to normal levels prior to this event. Yet 
livers at postmortem examination are congested even though portal pressures 
have returned to control levels (Brunson e^ al., 1966). Therefore, a dis­
parity may exist between portal pressure and liver pooling, particularly 
following the acute response.
It was found that endotoxin elicited a large fall in cardiac out­
put approximately 2 minutes after injection (Weil e^ aJ^ . , 1956a). The
7decline in cardiac output was accompanied by a slight rise in total 
peripheral resistance. Thus it appeared that the decrease in blood pres­
sure was the result of a diminished total blood flow and was not due to 
peripheral dilation. An experiment using an external reservoir, which 
received all venous flow and from which blood was pumped at a constant 
rate into the right atrium, revealed that endotoxin administration pro­
duced no immediate fall in canine blood pressure when venous return was 
held constant (Weil ^  ad., 1956b). Therefore, it was concluded that the 
early hypotensive condition was due to a lowered cardiac output caused by 
trapping of blood in the hepatic bed. Were the hypotension the result of 
dilation of peripheral vessels, the arterial pressure would be expected 
to decline despite a constant cardiac output. It was also evident that 
venous return to the heart was decreased because there was a rapid fall 
of the blood level in the venous reservoir. The inadequate cardiac out­
put was obviously not the result of myocardial failure since the heart 
was quite capable of pumping the constant amount of blood returned to 
it (Weil e_t a^., 1956b).
The reaction of the renal vascular bed to the lethal effects of 
endotoxin has also been evaluated. It was found that the kidney, too, was 
involved in the early phases of canine endotoxin shock. Renal perfusion 
studies revealed a fall in kidney weight which commenced 15-35 seconds 
postendotoxin (Hinshaw and Bradley, 1957). Since this early decline in 
renal weight occurred prior to systemic arterial hypotension, the weight 
loss appeared due to arteriolar constriction. When a kidney was perfused 
at constant arterial pressure, it was found that an initial decrease in 
renal blood flow was followed by an increase in flow (Hinshaw et al.,
1959). Thus, the renal vascular response to endotoxin is immediate 
arteriolar constriction which precedes vasodilatation. Altered renal 
functions postendotoxin appear to be secondary to hemodynamic derange­
ment and not a direct nephrotoxic action (Hinshaw et al., 1961c;
Gillenwater e^ a^., 1963; Hinshaw ^  al., 1959).
Hemodynamic alterations in the lung are also evident when endotox­
in is given to an anesthetized dog. An intact dog responds with an in­
crease in pulmonary vascular resistance (Kuida e^ aJ., 1961). The pul­
monary vascular response is usually evident at 90 seconds postendotoxin 
(Hinshaw et al., 1957). Results obtained in an isolated lung perfusion 
system were as follows: increases in pulmonary artery pressure, pulmonary
artery wedge pressure and lung weight. When the pre- and post-capillary 
vascular beds were examined, calculated venous resistances rose more than 
arterial resistances (Kuida e_t al., 1958). These changes observed in the 
vascular system of the lung were rapid in onset and disappeared by approx­
imately 30 minutes after the endotoxin was given. Thus, the lung presents 
an example of local pooling and venous constriction (Gilbert, 1960) during 
the early stage of endotoxin shock.
Unfortunately, there seems to be a paucity of information on the 
cerebral vascular bed during endotoxin shock. A report by Lillehei and 
MacLean (1958) states that no great increases in resistance were found in 
the carotid artery postendotoxin. It is possible that blood flow to the 
brain is diminished due to lowered cardiac output and systemic hypotension. 
Since the terminal phase of endotoxin shock exhibits respiratory arrest 
while the heart is still beating, severe medullary depression resulting 
from cerebral ischemia is suggested (Gilbert, 1960).
9The spleen, too, has been shown to participate in the canine 
vascular response to endotoxin. An early contraction of the splenic red 
cell reservoir causes an abrupt outpouring of concentrated blood directly 
into the portal vein (Boruchow and Abel, 1966). It is thought that this 
contraction response is related to the baroreceptor stimulus to the ad­
renals following acute arterial hypotension. It is evident that the state 
of the splenic blood volume at the time endotoxin is administered influ­
ences the early changes in hematocrit (Chien ejt £l., 1965a).
Despite the fact that the shock syndrome often terminates with 
cardiac failure (Crowell and Guyton, 1962), there is evidence that endo­
toxin exerts no direct effects upon the myocardium. Frohlich and co­
workers (1962) reported a decrease in coronary vascular resistance when 
the whole animal was included in the perfusion circuit while others 
(Londe e^ , 1967) demonstrated that the vasculature of the isolated 
perfused heart is unaffected by endotoxin. In the intact animal, ventri­
cular function may actually be enhanced during the early hypotensive 
phase due to increased sympathetic drive. Thus, it is suggested that the 
irreversibility is primarily determined by peripheral mechanisms (Visscher,
1965), although cumulative myocardial damage or progressive deterioration 
of sympathetic drive may contribute to the ultimate heart failure observed 
when shock is prolonged (Goodner, 1967). In contrast to the previous find­
ings, Moses and MacIntyre (1963) feel that the primary vascular episode 
in endotoxemia is a generalized impairment of cardiac function and that 
changes in other organs, such as the liver, are secondary to the diminish­
ed cardiac output. A similar point of view is expressed by Maxwell and 
co-workers (1959) who conclude that endotoxemia is associated with marked
10
impairment of myocardial function.
Endotoxin, often referred to as a "vascular poison," appears to 
have profound effects at the capillary level of the circulation. The re­
port of an increase in fibrinogen content of the thoracic duct was inter­
preted to mean that there was a large increase in capillary permeability 
to high molecular weight proteins (Chien ^  £l-> 1965b). Plasma protein 
concentrations have been shown to decline after endotoxin (Chien et al., 
1965b). The report of Lillehei and MacLean (1959) showed the secondary 
fall in arterial pressure to occur concomitantly with a significant de­
cline in circulating plasma volume. Hematocrit rises after endotoxin 
administration and is partially ascribed to extravasation of vascular 
fluid (Chien e^ al., 1965a). It is concluded that endotoxin poisoning 
includes, as either a direct or an indirect effect, permeability changes 
(Visscher, 1965). The indirect action on the capillary bed might be at­
tributed to liberated chemical mediators or to neural mechanisms.
The nervous system has been implicated as a site of increased 
permeability by Eckman and co-workers (1958). They demonstrated that endo­
toxin rendered cerebral vessels of rabbits permeable to injected colloidal 
dyes. A more recent publication (Clawson e^ £l., 1966), utilizing the 
electron microscope to study the distribution of colloidal iron oxide in 
cerebral capillaries of rabbits, found that two hours after endotoxin ad­
ministration there was a significant accumulation of iron oxide particles 
in the cerebral capillary epithelial cells of endotoxin-shocked animals.
The authors concluded that endotoxin caused the cerebral capillary endo­
thelial cells to become more actively phagocytic.
In summary, the early hemodynamic responses of the dog associated 
with endotoxin administration are as follows: (1) systemic hypotension;
11
(2) diminished cardiac output due to decreased venous return; (3) vascu­
lar pooling, especially in the hepatic bed; (4) arteriolar constriction 
in the kidney; and (5) pulmonary venous constriction. Thus, the early 
results of endotoxin appear to be redistribution of blood in the vascu­
lar bed. The primary hypotensive state might be described best by saying 
that a disparity exists between the circulating blood volume and the ca­
pacity of the vascular bed. In contrast, the late phase of endotoxin 
shock is characterized by a gradual decline in systemic arterial pres­
sure, extravasation of fluid into the intestinal area, diminished venous 
return and evidences of dilatation or circulatory failure. The decrease 
in venous return can be explained in part by progressive pooling in the 
gut wall. It is important to note that this cannot be the only site of 
loss of vascular fluid since the eviscerated dog also becomes hypotensive 
and dies when endotoxin is administered (MacLean and Weil, 1956). Pool­
ing does occur in the eviscerated dog but its site is unknown (Hinshaw 
et al., 1958).
Other Canine Reactions to Endotoxin 
It should be noted that although many toxic reactions to endotoxin 
occur in the circulatory system, not all of the lethal effects of endotox­
in occur there. The endotoxin-shocked dog exhibits severe bloody diarrhea, 
retching and vomiting, acidosis and other metabolic disturbances, oliguria, 
coagulation disturbances, and leucopenia followed by leucocytosis. Copious 
diarrhea is observed 30 to 60 minutes postendotoxin (MacLean and Weil,
1956). Loss of fluid due to diarrhea tends to promote late increases in 
hematocrit (Chien _et £l., 1965a). At postmortem examination, the bowel 
reveals numerous congested and necrotic areas which suggest that a loss of
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fluid into the tissue has occurred (Fenner and Bernheim, 1942; Burrows, 
1951).
The dog responds to endotoxin with rapid development of a meta­
bolic acidosis characterized by a marked and significant increase in lactic 
acid and a fall in bicarbonate ion and pH. These changes occur within 14 
minutes after endotoxin. The metabolic acidosis appears to be the result 
of stagnation of the circulation and accumulation of metabolites as a 
consequence of low blood pressure (Hardaway ^  £l., 1961; Rosenberg and 
Rush, 1966). Most of the metabolic disturbances seem to be associated 
with derangements in carbohydrate metabolism which are thought to be the 
result of two mechanisms: one being a direct action of endotoxin on
cellular metabolic processes and the other being the inadequate tissue 
perfusion (Rosenberg and Rush, 1966). An initial hypoglycemia is followed 
by hyperglycemia, with depletion of liver glycogen (Berry and Smythe, 1959). 
The hyperglycemia and glycogen depletion are thought to be the result of 
increased hepatic phosphorylase activity because endotoxin seems to con­
vert most of the liver phosphorylase to the active form (Hamosii and 
Shapiro, 1960). High levels of extracellular glucose are maintained until 
the animals begin a slow recovery or suffer a rapid death (Green and Stoner, 
1954).
Urine output is often severely diminished during shock (Vick et al.,
1963). This appears to be the result of an embarrassed filtration rate 
caused by the intense arteriolar constriction secondary to systemic hypo­
tension (Visscher, 1965; Emerson et_ al., 1966).
Abnormal alterations in the coagulation mechanisms are evident 
soon after endotoxin is injected (Cavanagh and DeCenzo, 1963; Cans et al..
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1963). There is a rapid and dramatic fall in blood fibrinogen levels 
within 20 minutes but normal levels are regained within four to six hours. 
There is also a temporary depletion of platelets and prothrombin time is 
prolonged (Corrigan ^  £l., 1968). These changes are attributed to deple­
tion of blood coagulation factors in an intravascular clotting episode 
(Hardaway and Johnson, 1963). Activation of the Hageman factor has been 
suggested as the initial step in the resultant coagulation process (Nies 
et al., 1968).
Endotoxin activity elicits several changes in the formed elements 
of the blood. Endotoxin particles adhere to platelets and ultimately re­
sult in platelet destruction (Spielvogel, 1967; Des Prez, 1967). A pro­
found polymorphonuclear leucopenia occurs within one hour after endotoxin 
and persists for two or three hours (Weil and Spink, 1957). This phenom­
enon, described by Delaunay in 1943, was attributed to retention of leu­
cocytes in capillaries of the lung, liver, and spleen. Neither leucopenia 
or thrombocytopenia is a specific manifestation of endotoxin. Both have 
been observed in anaphylactic shock (Rocha e Silva, 1950).
It has been hypothesized that endotoxin acts upon granulocytes to 
release intracellular enzymes, collectively known as lysosomes by Nies 
and co-workers (1968). These authors reported increased plasma levels of 
free lysosomal enzymes postendotoxin. Lysosomes may play an essential 
role in pathogenesis of the shock state, producing the necrotic lesions 
associated with endotoxin administration. The special significance of 
lysosomal enzymes rests in their role in autophagocytosis and potential 
initiation of more distant cellular injury (Berman et al., 1969). Since 
lysosomal activity is enhanced in an acid medium, the acidotic condition
14
of the shocked animal provides optimum conditions for these functions 
(Sutherland ^  a]^ ., 1968). There are reports of especially accelerated 
lysosomal release from splanchnic tissue (Sutherland ad., 1968), notably 
acidotic in the shocked dog, as evidenced by elevation of acid phosphate 
levels in thoracic duct lymph (Berman e^ a^., 1969).
Many of the characteristic pathologic consequences of endotoxin 
are also elicited in anaphylactic or allergic states. It has been report­
ed that the initial phase of canine endotoxin shock involves an immune 
mechanism of the anaphylactic type in which endotoxin, acting as an anti­
gen, reacts with antibody in the presence of complement resulting in lib­
eration of vasotoxic substances (Spink et a]^ ., 1964). It has been shown 
that fibrin participates in the pathogenesis of the Generalized Shwartzman 
Reaction (GSR) by Bohle and co-workers (1959). Subsequently, Lee (1964) 
revealed that a decisive feature of the GSR is the inability of the re­
ticuloendothelial system (RES) to clear the blood of fibrin. Endotoxin 
attenuates the phagocytic ability of the RES (Arredondo, 1963). It appears 
that the intravascular fibrin deposition occurring in association with 
endotoxin injection is very similar to the pathologic condition produced 
by the classical GSR (Stetson, 1955). Endotoxin apparently causes fibrin 
to collect in capillary beds, especially in the kidney and lungs (McKay 
et al., 1966). The subsequent plugging of capillaries could cause the 
tissues to become hypoxic (Braude, 1964). However, it seems unlikely that 
vessel plugging plays a critical role in shock, since it has not been noted 
as a prominent feature during in vivo microscopic studies (Gilbert, 1960). 
Extensive studies of canine endotoxin shock have fortified the concept 
that endotoxin shock is an expression of acquired bacterial hypersensitiv­
ity (Kim and Watson, 1966). The severity of the shock appears dependent
15
upon two factors; the dose of the antigen (endotoxin) and the degree of 
hypersensitivity (Spink, 1967).
Endotoxins are commonly described as poor antigens and unable to 
stimulate production of high titers of antibodies. Actually, relatively 
small doses of purified endotoxin result in high antibody titers. The 
poor reputation of the endotoxins as antigens rests largely on their 
inability to stimulate formation of high titer antitoxic sera (Morgan,
1941). Thus, agglutinin and precipitin titers may be high but the anti­
serum will not neutralize the toxic effects of endotoxin (Burrows, 1951; 
Thomas, 1954).
Role of the Nervous System
The nervous system is occasionally implicated in the pathogenesis 
of Gram-negative shock. Reilly jet (1934) injected small amounts of
endotoxin into the perisplanchnic area and observed hemorrhagic necrosis 
in the bowel wall. They reported injection of endotoxin about the splanch­
nic nerve to be more effective than its intravenous administration. Fine 
and Minton (1966) asserted that death from endotoxin is caused by the loss 
of integrity of the blood vessels in the splanchnic area as a result of 
excessive and unrelenting release of catecholamines produced by the splanch­
nic sympathetic nerves. Fine's thesis is that the lethal effect of endo­
toxin requires an intact sympathetic nerve supply to the splanchnic tis­
sues and that the injury to tissues in the splanchnic region after endo­
toxin is caused by norepinephrine. He further proposes that endotoxin 
does not kill the host by direct infliction of injury on blood or tissues. 
Palmerio et al. (1963) proposed that the refractory state of shock is
16
the result of a reaction of the nervous system to prolonged hypovolemia 
or to bacterial toxins. The result of this, the authors proposed, was 
that the nervous system evoked excessive catecholamine activity and a 
reduction of flow everywhere in the peripheral circulation. The conse­
quence of this reduction of flow was a generalized functional damage with 
the most critical disturbance occurring in the organs of the splanchnic 
area, particularly the intestines and liver. They found that celiac 
blockade relieved vasoconstriction in the splanchnic area and promoted 
survival after endotoxin. These results, however, were not confirmed by 
Emerson e_t (1965) in a series of chronic splanchnic denervated
dogs administered endotoxin. Their results showed no difference in the 
hemodynamic response in splanchnic denervated or non-denervated dogs 
given endotoxin, and there were no survival benefits in the denervated 
group. In summary, these authors observed that denervation of the ab­
dominal visceral sympathetic nervous supply gave no apparent protection 
in endotoxin shock.
It has been suggested that the hypothalamus plays a role in 
mediating the pyrogenic effects of endotoxin (Bard and Woods, 1959). 
Bennett and co-workers (1957) observed that intracisternal injection of 
only one thousandth of the usual intravenous dose produced fever in 
rabbits. Porter and Kass (19.65) concluded that there are graded cerebral 
sites of sensitivity to endotoxin and that the posterior hypothalamic 
area is the most sensitive. Their findings indicate that the lethal 
action of endotoxin is manifested, in part at least, through mediation of 
the posterior hypothalamus, but they failed to determine whether this was 
an indirect or direct action of the toxin. Braude (1964) discussed one
17
possibility of an indirect action of endotoxin on hypothalamic centers 
following release of a pyrogen from white cells and its subsequent cir­
culation to the brain, and another possibility of a direct action of endo­
toxin on the hypothalamus after reaching it from the blood stream via the 
cerebrospinal fluid. Others have postulated an action of endotoxin in the 
central nervous system leading to altered hemodynamics (Block et £l.,
1966), Kovats (1967) has proposed that the primary toxic action of endo­
toxin is in the autonomic nervous system. He has stated that experimental 
observations show that the autonomic centers of the central nervous system 
have a particularly marked sensitivity to endotoxin. He has concluded 
that one of the main targets of endotoxin is the central nervous system, 
especially the brain, and that the vascular effects of endotoxin may be 
of a pure adrenergic nerve-dependent character. Although the nervous sys­
tem may participate in the response to endotoxin, it appears that the 
initial and direct effects of endotoxin in the dog and cat are not mediat­
ed through the central nervous system (Ravdin and Hardy, 1962), since in­
tact nervous pathways from the brain to the periphery are not necessary 
for the elicitation of endotoxin shock (Weil e_t aJ. , 1956a). Shock and 
the classical pathological changes are not limited to an animal with an 
intact brain.
Role of Vasoactive Agents 
In attempting to elucidate the mechanisms by which endotoxin exerts 
its toxicity, many investigators have incriminated numerous vasoactive 
agents as the culprits responsible for the pathogenesis of endotoxin shock. 
In vivo and in vitro studies have reported that endotoxin elicits the re­
lease of histamine (Schayer, 1960), serotonin (Rosenberg e^ , 1961)
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and a vasoactive polypeptide-like substance (Kobold £t al,, 1964). Fine 
and Minton (1966) implicated catecholamines released in the splanchnic 
tissues as the initiators of the lethal effects of endotoxin. The renin- 
aldosterone system is also activated during the course of shock (White 
et al . , 1967).
Vick (1965), utilizing a bioassay consisting of an isolated vein 
in a perfusion circuit with endotoxin-shocked dogs, presented evidence 
that the response to endotoxin can be divided into two phases, each 
initiated by a separate vasoactive substance. Histamine is said to pre­
dominate during the primary phase and catecholamines during the second.
It has been repeatedly reported that plasma levels of histamine are ele­
vated post-endotoxin in the dog (Hinshaw et al., 1960; Hinshaw et al., 
1961a; Hinshaw et al., 1962a; Kobo Ld ejt £i., 1964; Spink £t £l. , 1964); 
and in the primate (Hinshaw ejt , 1961b) . The mechanism responsible 
for elevated histamine levels is said to be acceleration of the rate of 
histamine synthesis due to increased activity of histidine decarboxylase 
(Greisman, 1960; Schayer, 1960). There is a progressive increase of the 
histamine:histidine ratio which is related to the relative rates of forma­
tion, conversion, and destruction of the two components (Hinshaw e^ al., 
1961a). The rise in plasma histamine might be attributed to the marked 
decrease in numbers of circulating platelets and white blood cells 
(Graham et al., 1955) found during early endotoxin shock (Weil and Spink,
1957). Comparisons of the actions of histamine and endotoxin have dis­
closed definite similarities of action in a number of parameters: early
increase in portal venous pressure coincident with a decrease in venous 
return, pooling, and a rapid decrease in systemic arterial pressure;
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lowered pH; and elevated hematocrit (Hinshaw et al., 1962a), Post­
mortem findings were also similar (Jordan ^  £l•» 1965),
Contrary to the reports that histamine levels are pronounced post­
endotoxin, Corrado ^  al, (1964), and Jacobson e^ (1964) found no
elevation of plasma histamine levels after endotoxin, Jacobson and co­
workers (1964) also reported decreased vascular responsiveness to hista­
mine during endotoxemia and found anti-histamine drugs to be ineffective 
in modifying the hemodynamic response to endotoxin. These investigators 
used a less toxic dose of endotoxin and suggested that elevated histamine 
levels postendotoxin were elicited by anaphylactic reactions to massive 
endotoxin doses.
Serotonin has been postulated as another vasoactive substance 
active in promotion of the shock state accompanying injection of endo­
toxin, (Rosenberg e£ al^ , , 1959; Rosenberg £t aJ^ ,, 1961), A marked de­
cline in serum serotonin occurs concomitantly with platelet clumping and 
breakdown postendotoxin (Davis ^  £l•> 1960), This decreased serotonin 
level persists throughout the postendotoxin period. It is important to 
note the type of anticoagulant used in these studies when interpreting 
data on serotonin levels. Heparin produces spontaneous platelet aggre-
y  / V  V
gation; hence, citrate or EDTA is to be preferred (Raskova and Vanecek,
1964), The report of Davis and co-workers (1960) used EDTA as the anti­
coagulant yet communnications from Jacobson al, (1964) and Rosenberg 
et £l, (1961) utilized heparin in assays of serotonin levels. Rosenberg 
and co-workers (1959) failed to report the anticoagulating agent employed 
in their studies.
The catecholamines have been suspected as being responsible for
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the pathogenesis of Gram-negative shock since Fenner and Bernheim (1942) 
pointed out the similarity between the pathologic changes of endotoxin 
shock and the lesions produced by epinephrine infusion, Frank (1944-45) 
found that epinephrine augmented the intestinal congestion associated with 
canine endotoxemia. The work of Zweifach £l, (1956) promoted the con­
cept that an abnormal response to the catecholamines might be an important 
factor in the lethal effects of endotoxin. They concluded that endotoxin 
alters the reactivity of the blood vessels to epinephrine and norepine­
phrine. However, Meyer and Ballin (1959) and Hinshaw et al, (1958b) fail­
ed to confirm the previous findings. It has subsequently been revealed 
that no significant changes in epinephrine levels are found until the 
pre-terminal stages while norepinephrine levels are elevated throughout 
the period postendotoxin (Ravdin and Hardy, 1962; Rosenberg et al,, 1959; 
Rosenberg _et a^,, 1961), Kovats, in a review article, postulated that 
catecholamines initiate the primary toxic events in the endotoxin reaction 
(Kovats, 1967), It would be difficult, however, to harmonize his view with 
recent findings in the endotoxin-shocked primate which does not show ele­
vated catecholamine levels until at least 2 hours after endotoxin admin­
istration (Hinshaw et al,, 1967; Guenter al,, in press), A major un­
answered question relates to whether the release of catecholamines is 
■'damaging" or "protective," Studies in dogs showed adrenalectomized dogs 
exquisitely sensitive to the deleterious effects of endotoxin (Hinshaw 
et al., 1964), suggesting a possible protective role of catecholamines 
in the shock reaction.
The polypeptide bradykinin has been suspected of playing a prom­
inent role in endotoxin shock (Beraldo, 1950; Aldrete e_t ^ , , 1966;
Gilbert, 1960), Polypeptides are frequently released by proteolytic
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enzymes (Gaddum, 1955), and there is evidence of proteolysis after endo­
toxin (Lockwood, 1946; Westphal, 1957). Aldrete et aly (1966) discussed 
the possible roles of vasoactive polypeptides in septic shock, suggest­
ing that local release of polypeptides might produce low vascular resist­
ance at sites of inflammation. In effect, this would function like a 
large arteriovenous shunt, increasing flow to the inflamed site. Poly­
peptide release may possibly account for local and generalized vascular 
changes in endotoxin shock including alterations in flow, vascular re­
sistances, and capillary permeability. The actions of bradykinin resemble 
those of histamine (Kontos e^ £l., 1964). It stimulates visceral smooth 
muscle, but relaxes vascular smooth muscle, dilates capillaries and in­
creases capillary permeability (Aldrete £t jd., 1966; Kontos et al.,
1964). These alterations have all been reported to result from injection 
of endotoxin and may occur after the release of both histamine and brady­
kinin. Kobold e£ a]^ . (1964) reported the releases of histamine, sero­
tonin, and a vasoactive polypeptide-like substance after endotoxin in 
dogs.
The renin-angiotensin system is reportedly activated after endo­
toxin in dogs (Vaughn _et ad., 1967). It is considered to be responsible 
for a large part of the recovery phase of shock by effecting an increase 
in blood pressure.
Substantial evidence has been presented that administration of bac­
terial endotoxin results in the release of several vasoactive materials.
The most probable explanation of events occurring at the vascular level 
postendotoxin will be an interaction of endotoxin and the various sub­
stances released. It appears that none of the previously mentioned agents
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can be indicted as the primary mediator of early endotoxin shock 
(Jacobson ^  , 1964). It should be considered that vascular react­
ivity may be substantially altered when serotonin levels are significantly 
lowered in the face of elevated catecholamine and histamine values 
(Schayer, 1960). The increased catecholamine levels may have a greater 
effect than their concentrations tend to indicate (Rosenberg e^ a^.,
1959) .
This review has demonstrated the great complexity of the vascular 
responses to endotoxin. There are without doubt a multitude of endogen­
ously released vasoactive agents activated in response to injections of 
endotoxin. These may be released into circulating blood or activated 
locally at sites of vascular smooth muscle. The kinds and concentrations 
of vasoactive agents may vary between species of animals, may be modified 
as a function of the dose of endotoxin (Davis e^ , 1961) and probably 
vary in accordance with time of release during the postendotoxin period.
The canine response to endotoxin has been emphasized because of the 
great bulk of research carried out on this species. Caution should be con­
tinually exercised however, in extrapolating data to another species be­
cause of marked species differences, exhibited most dramatically in the 
primates (Kuida £t a^., 1961).
Current Therapy for Endotoxin Shock
Endotoxin often initiates critical clinical situations (Altemeier,
1967). Therefore, exhaustive searches have been undertaken to find drugs 
capable of reversing the septic shock state. Numerous investigators have 
reported survival benefits from corticosteroids (Lillehei and MacLean,
1959; Spink and Vick, 1961; Jaques and Jaquet, 1964; Nagy e^ , 1964;
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Weil and Whigham, 1965; Thomas and Brockman, 1968). Today, steroids 
are widely employed in treatment of shock patients. The mechanisms by 
which steroids reverse the shock state are not well defined. It has 
been well established that supraphysiological doses of the steroids must 
be utilized in order to obtain beneficial actions (Weil and Whigham,
1965). These compounds apparently act as drugs rather than replacement 
hormones. Thus, they play a pharmacological rather than a physiological 
role in combating shock (Weil and Whigham, 1965). Nagy £l. (1965) 
suggested that recovery from a hypotensive to a normotensive state might 
be due to an increase in cardiac output. This augmentation of output is 
reportedly the result of prevention of increased peripheral resistance 
rather than an inotropic cardiac action (Nagy eit a^., 1965). High doses 
of corticosteroids, vasodilators in both dogs and humans, may oppose the 
compensatory constriction of the shock state and thus prevent ischemic 
tissue injury (Sambhi e^ , 1965). The vasodilator activity may also 
be responsible for decreasing the amount of anaerobic metabolites by pro­
moting a better peripheral circulation (Nagy £l •> 1965). Vaughn 
and others (1967) reported that prednisolone specifically produced an 
improvement in the mesenteric circulation of shocked animals. Recent work 
by Dietzman et al. (submitted for publication) has shown the corticoster­
oids to significantly decrease peripheral vascular resistance and increase 
systemic oxygen consumption of shock patients. Still another action attri­
buted to the steroids is stabilization of lysosomal membranes (Lefer and 
Martin, 1969). This could prevent the following sequence of events in 
the shock state: disruption of lysosomes, release of proteases, and
cleavage of plasma proteins. Thus it appears that the actions of steroids
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in combating the shock syndrome are numerous and diverse.
Recognition of the presence of numerous vasoactive agents during 
the septic shock state has stimulated interest in the use of drug antag­
onists to reverse the shock syndrome (Kalas and Jacobson, 1964). Anti- 
histaminic compounds (Tsagaris £t al., 1963), anti-adrenergic substances 
(Gourzis e£ al., 1961; Lillehei, 1962), anti-serotonin drugs (Tsagaris 
^  al., 1963), reserpine, which depletes catechol stores (Shimamoto £t
II
al., 1958), and anti-inflammatory agents (Erdos et al., 1967) have all
been suggested for the therapy regimen of shock. Reports from Northover
II
and Subramanian (1962), and Massion and Erdos (1966) revealed that sali­
cylate pre-treatment prevented the shock-like hypotensive state associat­
ed with endotoxin administration in dogs while Meli £t al. (1964) dis­
closed that aspirin effectively reversed endotoxin-induced lung inflamma­
tion in mice. Thus, it appeared that an anti-inflammatory agent, i.e. 
salicylate, was capable of obviating some of the symptoms of Gram-negative 
shock. This dissertation research project was undertaken to evaluate the 
actions of salicylates in endotoxin shock in hopes of gleaning information 
into the evasive mechanisms of action of the endotoxins.
The communication from Northover and Subramanian (1962) pointed
out that pre-treatment with salicylates protected dogs from the arterial 
hypotension associated with endotoxin administration. No subsequent re­
ports of the phenomenon were published by these authors. It appeared that 
the protective effects of salicylates in endotoxin shock were worthy of 
further and more detailed investigation.
The Working Hypothesis 
The basic observation that salicylates obviated the systemic
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hypotension associated with administration of endotoxin was the stimulus 
for the present dissertation. The research centered on the following 
question: How do salicylates prevent the endotoxin shock state? Endo­
toxin was known to be acting at various vascular sites to produce a 
lowered blood pressure and it was hypothesized that a vascular action of 
the salicylates might be responsible for reversal of the shock symptoms. 
Previous research, documented earlier in this paper, has shown that 
endotoxin acts at the pre-capillary, capillary, and post-capillary level 
of the vascular system. The results of these actions are ultimately 
intravascular and extravascular sequestration of blood. Loss of circulat­
ing blood volume is said to be responsible for the lowered blood pressure. 
Therefore, it was hypothesized that the salicylates were preventing the 
early toxic vascular reactions of endotoxin in the liver and the late 
deleterious effects which result in extravasation of fluid. A recent 
symposium on salicylates (Smith, 1966a) revealed anti-inflammatory act­
ivity of the salicylates to be due to antagonism of action of bradykinin, 
histamine and slow reacting substance. An investigation of the capillary 
bed and post-capillary area following salicylate and endotoxin adminis­
tration was deemed necessary in order to elucidate some of the actions 
of salicylates in endotoxin shock.
This work was undertaken to accomplish the following objectives: 
(1) document the ability of salicylates to protect dogs from endotoxin 
shock; (2) assertain the role of salicylates in promoting survival after 
endotoxin; (3) investigate and evaluate the hemodynamic responses follow­
ing salicylate pre-treatment; and (4) attempt to explain the mechanisms 
by which salicylates protect the animal from a lethal dose of endotoxin.
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It was hypothesized that the salicylates were acting in some way to 
reverse the effects of endotoxin, and this investigation was designed 
to elucidate some of the sites of action. Although many researchers have 
looked in vain for substances possessing the ability to treat patients 
suffering the effects of endotoxemia, this dissertation was not under­
taken to promote the use of salicylates for treatment. The salicylates 
were merely employed as a tool by which it was possible to examine the 
actions of endotoxin.
The initial studies undertaken were pilot experiments which 
consisted of administration of the salicylate (Alka-seltzer was used 
exclusively in the first studies) prior to injection of an LDgg dose of 
endotoxin. An LDgg dose was chosen for several reasons. It simulated 
the clinical conditions where approximately 80 per cent of patients 
suffering from Gram-negative bacteremia succumb. This dose also assur­
ed lethal effects but was not so potent as to prevent observation of 
protective effects of the salicylates. Although the LDgg dose of endo­
toxin was routinely employed, the salicylate dose was varied. It soon 
became evident that the protective effects of the salicylate were direct­
ly related to the dose, but as the dose was increased to over 100 mg/kg 
the dogs began to show evidence of salicylate poisoning: increased
body temperature and hyperventilation often followed by respiratory 
arrest and death. Optimum protective benefits were observed at the 
highest doses which did not produce toxic manifestations (100 mg/kg).
After the salicylate dose was determined, the actual disserta­
tion protocol was established and begun. A series of survival experi­
ments was carried out which consisted of administration of salicylate
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prior to the toxin. The animals were observed for 4 days. Those sur­
viving at 96 hours postendotoxin were called permanent survivors. This 
time period was chosen on the basis of previous work with endotoxin- 
shocked dogs. The majority of dogs which succumb to the lethal effects 
of endotoxin will perish within the first 24 to 48 hours. Any animal 
living at 96 hours after endotoxin is usually a permanent survivor.
The next phase of this investigation was aimed at the hemodynamic 
responses. Systemic arterial and portal venous pressures were monitored 
in intact animals while cardiac output was measured in open-chest animals.
Since the liver was known to be a major site of pathological 
changes in endotoxin shock, a series of liver perfusion studies was de­
signed to evaluate the liver response to salicylate pre-treatment. Hepat­
ic arterial and portal venous pressures were monitored.
The final portion of the study was focused on the capillary bed.
A technique was employed which allowed the measurement of pressure in 
the capillary bed. Assessment of the microcirculatory bed was included 
to evaluate mechanisms of fluid loss during endotoxin shock.
CHAPTER II 
MATERIALS AND METHODS
The subjects of this investigation were adult mongrel dogs, all 
of which were anesthetized with intravenous injections of sodium pento­
barbital, 30 mg/kg.
Determination of the Canine Hemodynamic Response 
to Endotoxin and Acetylsalicylic Acid
One hundred and fifty-six animals were utilized in the initial 
phase of this investigation. Three major types of studies were employed: 
(1) survival studies; (2) hemodynamic evaluations on intact animals; and 
(3) venous return preparations. The distribution of animals was as 
follows: 45 animals for establishment of the LDgg dose of endotoxin, 51
for studying effects of acetylsalicylic acid (ASA) on survival after endo­
toxin, 44 for determination of the hemodynamic response, and 16 for 
measurement of venous return. In each case a sufficient number of ani­
mals was employed to permit statistical evaluation of data.
An approximate LDgg dose of endotoxin was established in a group 
of 45 dogs. Animals living 4 days after intravenous Escherichia coli 
endotoxin (Difco Laboratories, Detroit, Mich.) administration were con­
sidered permanent survivors. The endotoxin doses utilized varied between 
0.4 and 1.0 mg/kg.
The effects of pre- and post-treatment with acetylsalicylic acid
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(ASA) (aspirin, U.S.P., Merck and Company, Inc., Rahway, N.Y.) or buffered 
acetylsalicylic acid (Alka-Seltzer, Miles Laboratories, Inc., Elkhardt, 
Ind.) on survival after endotoxin were studied in a group of 51 dogs.
Again, 4 days was used to designate permanent survival. Buffered 
ASA was prepared by dissolving six Alka-Seltzer tablets in distilled water 
and adjusting to a final volume of 60 ml. The resulting concentration 
was 32 mg of ASA per ml. The 60 ml solution also contained the follow­
ing constituents: buffer (citrate), 6.64 g; bicarbonate, 11.52 g; and
monocalcium phosphate, 1.23 g. The pH of the solution was 7.07. A dose 
of 100 mg/kg, calculated on the basis of an ASA concentration of 32 mg/ml 
was infused intravenously over a 30 minute period by means of an infusion 
pump (Harvard Infusion Apparatus). The infusion rate varied between 1-2 
ml/min. Infusion was carried out slowly because deleterious effects 
were encountered at higher rates of infusion. The predominant harmful 
effect observed by rapid infusion was marked elevation of body temperature. 
In animals receiving endotoxin alone, saline was infused in a volume equal 
to that given animals receiving buffered ASA, In pre-treatment studies, 
endotoxin was injected after total administration of the ASA. In post­
treatment experiments, infusion of buffered ASA was commenced 15 minutes 
after endotoxin injection, when dogs were usually in the most marked hypo­
tensive condition; the infusion continued for 40 minutes. In additional 
experiments, ASA (aspirin) was infused during the pre-endotoxin period. 
Aspirin powder was dissolved in 90% ethyl alcohol to achieve a final con­
centration of 150 mg/ml. The pH was 7.03.
Approximately 45 mg/kg was infused intravenously. This dose was 
used because the aspirin powder was not buffered. The alcohol and ASA
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solution was infused with a saline flush (50-80 ml) at a constant rate 
during a 30 minute period. The volume of alcohol infused varied between 
three and four and one-half ml.
Hemodynamic Measurements in Intact Animals 
Forty-four animals were used in this phase of the study, A saline- 
filled cannula, attached to a Statham pressure transducer, was introduced 
into the femoral artery, A similar cannula was inserted into a splenic 
vein of 10 animals, exposed after a midline laparotomy, and advanced 
to the portal vein. These procedures permitted the measurement of fem­
oral artery and portal vein pressures, respectively, which were record­
ed on a Sanborn direct writing recorder. Hematocrit and pH values were 
determined at various intervals. The 44 animals were administered endo­
toxin alone, buffered ASA alone or in combination with endotoxin or ASA 
alone or in association with the Gram-negative toxin. The endotoxin 
dose was 0,4 mg/kg (LDg2 , as determined in the previously mentioned sur­
vival study), Experiments were carried out for 120 minutes postendotoxin 
administration.
Measurement of Venous Return 
A group of 16 dogs were utilized for this study. Each animal 
was placed in a supine position on a canine surgery table. Pressure 
measurements were made in the femoral artery as previously described. 
Following insertion of an endotracheal tube, the animal was respired on 
room air by means of a Starling constant volume respirator adjusted to 14 
to 16 strokes/min and 300 to 400 ml/stroke. The chest was then opened with 
a mid-sternal incision and retractors were employed to hold the chest in
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an open position.
The extracorporeal blood circulation was established according 
to the procedure described by Weil and co-workers (1956a) and later modi­
fied by Hinshaw and co-workers (1961a). The azygous vein was ligated so 
that all venous blood returned to the heart via the superior and inferior 
vena cavae. A slit was made in the pericardium to expose the heart and 
the phrenic nerves were ligated and severed. Large polyethylene cannulae 
were inserted upstream into the venae cavae, thus collecting all venous 
return and depositing it in a reservoir maintained at 40°C by means of 
a constant temperature water bath. A Sigmamotor pump was placed on the 
outflow side of the reservoir which pumped the blood through another 
cannula to the right atrium of the dog. The atrial cannula was introduced 
and securely tied into the auricle of the right atrium. Therefore, all 
venous return was collected in a reservoir and returned, by means of a 
pump, to the right atrium. Speed of the atrial inflow pump was repeated­
ly adjusted during each experiment so that venous return and cardiac in­
flow were maintained equal at all times. Central venous pressure was 
maintained at atmospheric pressure (0 mm Hg) by adjusting heights of vena 
caval drainage cannulae so that a repetitive flutter of the orifices of 
the central veins continually occurred throughout the experiments.
Following termination of surgical and technical procedures, 10 to 
15 minutes stabilization periods were allotted. Cardiac output (venous 
return) was periodically determined through the study by use of a grad­
uated plastic cylinder and stop watch, measuring blood draining from the 
inferior and superior and venae cavae. These experiments were carried out 
for only one hour owing to deterioration of the preparation beydnd this
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period.
These 16 animals were divided into three groups. Five dogs were 
administered only endotoxin, 0.4 mg/kg. Six animals were given buffered 
ASA, 100 mg/kg, prior to endotoxin. The remaining 5 dogs received buffer­
ed ASA and no endotoxin.
Total peripheral resistance was calculated by dividing mean sys­
temic arterial pressure by cardiac output (venous pressure = zero mm Hg). 
Standard deviations (S.D.) were derived utilizing the following equation.
S.D. =y (N-l)
In this equation x equals the deviations from the arithmetic mean and N 
is equal to the total number of experimental subjects. The standard de­
viation is a special form of average deviation from the mean. Standard 
errors (S.E.) were computed by dividing the S.D. by the square root of N. 
Significance levels were evaluated with the modified t-test (Arkin and 
Colton, 1958). This was a test for comparing means of unpaired observa­
tions and unequal variances, based on the assumption that the two samples 
from which the means were taken were uncorrelated.
The following formula was employed to calculate the p values:
P = J  (S.D.1 ) 2 +  (S.D.2)2 
' Nl Ng
where S.D.^ = standard deviation of the first sample, S.D.2 = standard 
deviation of the second sample, = number of items in the first sample, 
and N2 = number of item in the second sample.
Both S.D. and S.E. were computed because the S.D. was utilized 
in significance calculations while S.E. was employed in graphic illustra­
tions of data.
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Perfusion of the Liver 
A group of 19 dogs, weighing between 9 and 14 kg, comprised the 
subject population of the second phase of the present study. Each animal 
was placed in a supine position on a canine surgery table. Following a 
mid-line laparotomy incision, a splenctomy and gastrectomy were performed. 
The hepatic artery was isolated and carefully denervated surgically. The 
hepatic artery was cannulated and perfused with blood obtained from the 
femoral artery while the portal vein was cannulated with a perfusion sys­
tem from the inferior vena cava. The portal venous inflow catheter tip 
was placed just downstream from exiting veins. Sigmamotor pumps were 
interposed in each perfusion set-up. A constant blood flow to the hepat­
ic artery was delivered at physiological pressures (100-140 mm Hg), while 
constant flow to the portal circuit was delivered at pressures between 
6 and 15 mm Hg. The celiac, superior mesenteric, and inferior mesenteric 
arteries were separately ligated following removal of the spleen and 
stomach and cannulation of the hepatic artery. Care was taken to insure 
that blood flow to the hepatic artery and portal vein was only separate­
ly interrupted (less than 60 sec.) during the cannulation procedures. A 
continuous flow to the liver through at least one inflow vessel was main­
tained at all times during insertion of the cannulae.
Pressures were monitored via Statham pressure transducers on a 
Sanborn direct-writing recorder. Systemic arterial pressure was obtained 
by advancing a polyethylene catheter from the femoral artery into the 
aorta. Similar catheters were placed in the tips of the hepatic artery 
and portal vein inflow tubing to record pressures at those sites.
A period of 20 minutes was allowed to permit stabilization of all
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parameters after completion of surgical procedures. Fifty mg/kg of ASA 
dissolved in 90% ethyl alcohol (150 mg/ml) was administered intravenously 
to 12 animals. The ASA and alcohol (3-4.5 ml volume) infusion, administer­
ed via a Harvard infusion apparatus into the jugular vein, was simultan­
eously accompanied by a 30 to 40 ml saline flush. ASA injection was accom­
plished in 15 minutes. Seven of these animals then received an LDg2 dose 
of endotoxin (0.4 mg/kg) while the remaining 5 animals received no endo­
toxin and served as ASA controls. Seven other animals were administered 
alcohol and saline (no ASA) followed by endotoxin. All preparations were 
observed for 30 minutes after endotoxin was injected. The results ob­
tained were statistically evaluated with an analysis of variance calcul­
ation (Steel and Torrie, 1960). This calculation gave identical results 
to those obtained with the modified student t-test (Arkin and Colton,
1958).
Determination of Isogravimetric Capillary Pressure 
Thirty-seven anesthetized canine subjects were employed in the 
final episode of the investigation. The study was comprised of 10 endo­
toxin-shocked preparations and 7 sodium salicylate-treated (sodium sali­
cylate, USP, obtained from Mallinckrodt Chemical Works, St. Louis, Missouri) 
and endotoxin-injected dogs, all of which were observed at 4 hours follow­
ing endotoxin administration plus 15 control (no endotoxin) dogs. Another 
group of 5 animals was studied at 20 hours postendotoxin. At 4 hours 
postendotoxin the animal is usually in a deep state of shock. The 20 
hours observation group consisted of animals which might have been sur­
vivors of the toxin injection. The sodium salicylate, 80 mg/kg, was ad­
ministered intravenously in 10 ml of saline 3 minutes prior to endotoxin
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injection. A single shot injection was employed. The pH of the sodium 
salicylate solution was 7.71.
In each animal, one forelimb was surgically removed above the el­
bow. The area was shaved and all hair removed prior to surgery. A 
circular incision was made through the skin approximately 1 inch above 
the elbow. Surgical removal was carried out by sectioning muscle tissue 
between double ligatures. Care was taken to avoid ligation of lymphatics. 
All nerves were tied and severed while the brachial artery, brachial vein 
and cephalic vein were carefully dissected free for several centimeters. 
The bone was severed with an autopsy saw and the opening of the bone was 
immediately sealed with bone wax.
Following intravenous heparization, 5 mg/kg, the brachial artery 
of the leg was cannulated with plastic tubing extending through a Sigma­
motor pump, connected at its proximal end to the femoral artery of the 
donor dog. The leg veins were separately cannulated with plastic tubing 
leading to a reservoir placed in a constant temperature water both main­
tained at 40°C. Blood was returned to the femoral vein of the donor dog 
by means of another Sigmamotor pump. At the time of cannulation of the 
leg vessels, the dog side of each vessel was securely ligated to avoid 
bleeding.
The leg was then placed in a metal tray, suspended from one arm 
of a strain gauge weighing device and positioned above the venous drain­
age reservoir. The weighing apparatus consisted of a Wheatstone bridge 
attached to a strain gauge recording device which permitted continuous 
monitoring of changes in limb weight (Stish £t a]^ ., 1956).
Brachial artery pressure, cephalic vein and brachial vein
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pressures were monitored at the orifices of the vessels by means of needle- 
tipped catheters attached to Statham pressure transducers. Systemic art­
erial pressure was obtained via another cannula introduced into the fem­
oral artery and attached to another transducer. All pressures and changes 
in limb weight were registered on a Sanborn 6-channel recorder. Foreleg 
blood flows were measured with a graduated cylinder and stop watch. In­
itial flow rates to the limb were adjusted to the highest values at which 
the leg remained in an isogravimetric state. Screw clamps were placed on 
the venous outflow catheters so that adjustment of these clamps permitted 
alterations in venous pressures. An equilibration period of approximately 
20 minutes was permitted prior to commencement of the experimental pro­
cedures .
Hematocrit and pH values were determined periodically.
The limb was then perfused isogravimetrically at various rates of 
arterial inflow, according to a technique described by Pappenheimer and 
Soto-Rivera (1948). The isogravimetric condition was established by si­
multaneous adjustment of inflow rate and venous outflow pressures until 
the limb neither gained nor lost weight. Each isogravimetric state was 
maintained for a period of 5 minutes, and 5 to 10 minutes were allowed be­
tween each readjustment of flow and pressures. When a condition of iso- 
gravimetricity was attained, the foreleg blood flow and associated venous 
outflow pressures were recorded. Flows were randomly varied between 0 
and the highest possible flow attainable in the absence of weight gain. 
Venous pressures were separately adjusted to be equal in value. The 0 flow 
technique was previously described by Johnson e£ a]^ . (1966).
The isogravimetric capillary pressure (Pc^) is a value which is
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determined at a condition of momentary zero flow to the perfused leg.
When no blood is flowing to the limb and the limb is neither gaining nor 
losing weight, the arterial and venous pressures are equal. It is assumed 
that all pressures in the limb are equal at this time. Thus the arterial 
or venous pressure measured at an isogravimetric and zero flow state 
should represent the pressure in a capillary.
Statistics were performed by completely random design analysis of 
variance and Duncan's multiple-range test for difference between means 
(Steel and Torrie, 1960).
CHAPTER III 
EXPERIMENTAL RESULTS 
Canine Hemodynamic Response to Endotoxin
Survival Studies 
The results of the survival studies are depicted in Table 1.
All tables and several figures presented in this dissertation were 
previously published in the following journals: J. Pharm. Exp. Ther.
157: 665, 1967; Proc. Soc. Exp. Biol, and Med. 127: 332, 1968; and 
Am. J. Physiol. 214: 443, 1968. Permission was obtained from each 
journal to reproduce these tables and figures.
Dogs living 4 days after administration of endotoxin were con­
sidered permanent survivors. Fifty-one animals were utilized for this 
portion of the study. Of the 18 animals receiving only endotoxin (0.4 
mg/kg, an LDg2 dose as previously established in a series of 45 animals), 
22 per cent were permanent survivors. When 13 dogs were pre-treated with 
buffered ASA prior to endotoxin injection, the survival rate was 62 per 
cent. Fifty-eight per cent of another group of 12 dogs receiving aspirin 
(ASA, 45 mg/kg) survived the subsequent insult of endotoxin. Statistical 
analysis, comparing each pre-treated group to the endotoxin shocked group, 
revealed the p value to be less than 0.05. Another series of 8 dogs was 
administered endotoxin and then post-treated with buffered ASA. The
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TABLE 1
EFFECTS OF ASA ON SURVIVAL IN DOGS 
ENDOTOXIN (0.4 mg/kg)
ADMINISTERED
Groups
Number
of
Animals
Survival
Rate
Endotoxin only 18 22%
Treated Animals:
(1) Pre-treated with 
buffered ASA 
(100 mg/kg) 13 62%
(p<.05)
(2) Pre-treated with 
ASA (45 mg/kg) 12 58%
(p<.05)
(3) Post-treated with 
buffered ASA 
(100 mg/kg) 8 37%
(not signi­
ficant)
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survival rate in this group was 37 per cent, not statistically signifi- ' 
cant from the endotoxin group. Therefore, pre-treatment with buffered 
ASA or ASA had a significant effect on increasing the survival rate after 
endotoxin.
Hemodynamic Response of the Intact Animal 
Thirty-seven animals, divided into 4 groups, comprised this phase 
of the study. The results are shown in Figures 1, 2 and 3. Endotoxin 
(0.4 mg/kg) was administered to each of the animals in 3 of the 4 groups 
at zero time. Mean values plus or minus standard errors are represented 
for each of the 4 groups. In some instances, standard errors are not 
shown because they are smaller than the symbols. The systemic arterial 
responses are seen in Figure 1. Ten animals, given only endotoxin and 
represented by the open circles, responded with an initial precipitous 
decline in arterial pressure within 2 minutes. Pressures had recovered 
to near normal levels by 30 minutes but tended to decrease from 30 to 120 
minutes. A second group, consisting of 12 dogs, was pre-treated with buf­
fered ASA (100 mg/kg) prior to endotoxin administration. This group, de­
picted by the closed circles, revealed a slight drop in pressure at 2 
minutes but control levels were regained by 15 minutes and maintained 
throughout the experimental period. Statistical analysis of these first 
two groups revealed significant differences (p<.05) in pressure at all 
points past zero time. Solid squares represent the mean pressure values 
of 10 animals receiving only the buffered ASA (no endotoxin). Initial 
pressures were lower in this group than the other 3 groups and showed a 
slight tendency to increase throughout the 120 minutes. The fourth group 
(5 animals) was included to study the effects of the buffer components of
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Figure 1. Effects of Endotoxin and Buffered ASA Pre-Treatment 
on Systemic Arterial Pressure. Mean systemic arterial pressure values, 
plus or minus standard errors, are presented for four groups of animals 
(total number of animals = 37). Ten dogs were administered only endo­
toxin (0.4 mg/kg) at zero time. Twelve dogs received buffered ASA 
(100 mg/kg) prior to endotoxin injection. Buffered ASA alone was given 
to another series of ten animals. The fourth group consisted of five 
dogs which were given buffer prior to endotoxin administration.
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the ASA mixture. The buffer solution was infused in an amount equal to 
that used in the previous pre-treatment studies but without ASA. Open 
squares show the response to endotoxin with buffer pre-treatment. The 
pressure response of this group was very similar to that of the endotoxin- 
shocked group.
Figure 2 shows the hematocrit changes associated with endotoxin 
and ASA administration. The animals which received only endotoxin (open 
circles) exhibited an 18% rise in hematocrit while those dogs pre-treated 
with buffered ASA prior to endotoxin (closed circles) showed only a 9% 
increase. These 2 groups were significantly different at 60, 90, and 
120 minutes postendotoxin. The dogs getting only buffered ASA (solid 
squares) revealed a very slight rise in hematocrit which had returned to 
control levels by the end of the experimental period. Elevations in 
hematocrit readings were also seen in the endotoxin plus buffer group 
(open squares).
Periodic pH values are revealed in Figure 3. Acidosis was evi­
dent by 30 minutes and marked by 60 minutes in the endotoxin-shocked group 
of dogs (open circles). In contrast, dogs given buffered ASA before endo­
toxin showed a slight elevation in pH values. Again, these 2 groups were 
significantly different (p<.05) at all points beyond zero time. Buffered 
ASA caused a rise in pH in animals not subjected to endotoxin (solid 
squares). Dogs which were given buffer before endotoxin (open squares) 
responded with a decline in pH, somewhat similar to that seen in the 
endotoxin-shocked group.
Figure 4 presents portal venous pressure results from 10 intact 
animals in which the effects of unbuffered ASA (aspirin) were evaluated.
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Figure 2. Effects of Endotoxin and Buffered ASA Pre-treatment 
■:n Hematocrit. Mean hematocrit values, plus or minus standard errors, 
are presented for four groups of animals (total number of animals = 37).
Ten dogs were administered only endotoxin (0.4 mg/kg) at zero time.
Twelve dogs received buffered ASA (100 mg/kg) prior to endotoxin injection. 
Buffered ASA alone was given to another series of ten animals. The 
fourth group consisted of five dogs which were given buffer prior to 
endotoxin administration.
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Figure 3. Effects of Endotoxin and Buffered ASA Pre-treatment 
on pH. Mean pH values, plus or minus standard errors, are presented for 
four groups of animals (total number of animals = 37). Ten dogs were 
administered only endotoxin (0.4 mg/kg) at zero time. Twelve dogs re­
ceived buffered ASA (100 mg/kg) prior to endotoxin injection. Buffered 
ASA alone was given to another series of ten animals. The fourth group 
consisted of five dogs which were given buffer prior to endotoxin admin­
istration .
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Figure 4. Effects of Endotoxin and ASA Pre-treatment on Portal 
Vein Pressure. Mean portal vein pressure values, plus or minus standard 
errors, are shown for fifteen animals. Five dogs were given only endo­
toxin (0.4 mg/kg) at zero cime. The remaining ten dogs received ASA 
(40-50 mg/kg) prior to endotoxin injection.
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Five animals were administered intravenous infusions of ASA during the 
30 minute period prior to endotoxin while the remaining 5 animals re­
ceived only endotoxin (no ASA pre-treatment). Portal vein pressures were 
noticeably elevated in the animals receiving only endotoxin (open circles) 
while the ASA pre-treated dogs (closed circles) revealed only slight in­
creases. The portal venous pressure responses of the 2 groups were 
significantly different at each point beyond endotoxin administration.
Thus, at the conclusion of this phase of the study, the classical 
canine hemodynamic response to endocoxin had been reproduced and it was 
observed that buffered ASA pre-treatment obliterated systemic hypotension, 
portal venous hypertension, and acidosis while diminishing hemoconcentra- 
cion usually associated with the Gram-negative toxin.
The effects of post-treatment with buffered ASA were evaluated. 
Buffered ASA infusion was begun at 15 minutes after endotoxin adminis­
tration. Figures 5, 6 and 7 present the effects of post-treatment on 
systemic arterial pressures, pH, and hematocrit, respectively. Mean 
values, plus or minus standard errors, are shown. In some instances, the 
standard errors were smaller than the symbols and are not shown. Ten 
dogs received only endotoxin and their responses are shown by the open 
circles (these same 10 dogs are the endotoxin-shocked animals shown 
in Figures 1, 2 and 3). A group of 7 animals receiving the buffered ASA 
postendotoxin is depicted by the solid squares. The characteristic abrupt 
fall in systemic arterial pressure, at 2 minutes after endotoxin, was 
followed by recovery to control levels by 60 minutes (Figure 5). The 
pH levels were essentially constant throughout the 120 minutes (Figure 6). 
Butfered ASA post-treatment also depressed the rise in hematocrit (Figure
7 ) .
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Figure 5. Effects of Endotoxin and Buffered ASA Post-treatment 
on Systemic Arterial Pressure. Mean systemic arterial pressure values, 
plus or minus standard errors, are shorn for seventeen animals. Ten 
animals received only endotoxin (0.4 mg/kg) while the other seven dogs 
were given buffered ASA (100 mg/kg) at 15 minutes after endotoxin.
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Figure 6. Effects of Endotoxin and Buffered ASA Post-treatment 
on pH, Mean pH values, plus or minus standard errors, are presented for 
seventeen animals. Ten dogs received only endotoxin (0.4 mg/kg). Seven 
animals were given buffered ASA (100 mg/kg) at 15 minutes postendotoxin.
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Figure 7, Effects of Endotoxin and Buffered ASA Post-treatment 
on Hematocrit. Mean hematocrit values, plus or minus standard errors, are 
presented for seventeen animals. Ten dogs received only endotoxin (0.4 
iiig/kg). Seven animals were given buffered ASA (100 mg/kg) at 15 minutes 
poscendotoxin.
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Venous Return Preparations 
The results of 16 venous return experiments are shown in Figure 8. 
Infusions of ASA were carried out in two of the three groups between 0 
and 30 minutes. Endotoxin was administered intravenously in two of the 
three groups at 30 minutes. Mean values are shown for all three groups 
and standard errors are indicated where they are large enough to be shown. 
Open circles indicate the 5 animals which received only endotoxin (admin­
istered at the 30 minute time interval). These animals revealed the 
typical early response to endotoxin: (1) systemic arterial hypotension,
(2) diminished cardiac output, and (3) increased calculated total periph­
eral resistance. The 6 dogs which were infused with buffered ASA before 
endotoxin was administered at 30 minutes are shown by the closed circles. 
During the pre-treatment period, these animals exhibited essentially con­
stant pressures, but a rise was noted in cardiac output. Thus, total per­
ipheral resistance levels declined. Following endotoxin injection, sys­
temic arterial pressure, cardiac output and resistance values revealed 
little or no change. The third group, consisting of 5 dogs, received 
only the buffer solution (no endotoxin, no ASA). These animals, represent­
ed by solid squares, exhibited responses which were very similar to those 
seen in the ASA plus endotoxin group.
Effect of ASA on the Liver Response to Endotoxin 
The livers were perfused at constant rates of inflow in each study. 
Table 2 presents the mean values, plus or minus standard errors, of the 
flows in each of the three groups of experiments. Very similar flows were 
established in all 3 groups.
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Figure 8. Effects of Endotoxin and Buffered ASA Pre-treatment 
on Venous Return Preparations. Means values, plus or minus standard 
errors, for systemic arterial pressure, cardiac output and total peri­
pheral resistance are presented. Five dogs received only endotoxin at 
zero time. Six animals were given buffered ASA (100 mg/kg) prior to endo­
toxin. The other five dogs received buffered ASA and no endotoxin.
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TABLE 2
LIVER BLOOD FLOW (MEANS + BE)
Blood Flow
Group (number of animals) (ml/kg body wt.)
ASA Pre-endotoxin (7) 17.9 + 1.4
Alcohol blank Pre-endotoxin (7) 20.8+1.5
ASA (5) 19.4 + 3.3
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Mean values and standard errors of systemic arterial and portal 
venous pressures are seen in Figure 9. The classical response to endo­
toxin was observed in the 7 animals receiving only endotoxin; i.e., 
systemic arterial hypotension was associated with portal venous hyper­
tension.
In contrast, these responses were obliterated in the 7 animals 
which received ASA prior to endotoxin administration. Comparison of 
these two groups with statistical analysis showed significant differences 
in arterial pressures at 3, 15 and 30 minutes postendotoxin. Portal 
venous pressures were found to be significantly different at 3 and 15 
minutes after the toxin. Constant arterial and portal venous pressures 
were seen in the 5 dogs receiving only ASA (no endotoxin).
Hepatic artery pressure responses are found in Figure 10. The 
results are presented as changes elicited by endotoxin. Pressure was 
significantly elevated at 3 minutes after endotoxin in the 7 animals not 
pre-treated with ASA. Yet those 7 dogs which received ASA pre-treatment 
failed to show this increase in pressure. The five control studies (ASA, 
no endotoxin) also exhibited constant hepatic artery pressures.
Absolute hepatic artery pressures (means and standard errors) 
of the 3 groups are displayed in Table 3.
Effect of Endotoxin and Sodium Salicylate on the Isogravimetric 
Capillary Pressure in the Forelimb
Figure 11 shows the pressure-flow relationship obtained from a 
typical control (no endotoxin) experiment. Isogravimetric venous pres­
sures (Pv^) are plotted versus blood flows. Numbers indicate the sequence 
in which the points were obtained. The isogravimetric capillary pressure
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Figure 9. Effects of Endotoxin and ASA Pre-treatment on Systemic 
Arterial and Portal Venous Pressure, Mean values, plus or minus standard 
errors, are shown for nineteen animals. Seven dogs received only endotoxin 
(0.4 mg/kg) at zero time. Another seven animals were pre-treated with ASA 
(40-50 mg/kg) prior to endotoxin injection. Five dogs were given only 
ASA.
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Figure 10. Effects of Endotoxin and ASA Pre-treatment on 
Hepatic Artery Pressure. Mean values, plus or minus standard errors, 
are shown for nineteen animals. Seven dogs received only endotoxin 
(0.4 mg/kg) at zero time. Another seven animals were pre-treated with 
ASA (40-50 mg/kg) prior to endotoxin injection. Five dogs were given 
only ASA.
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TABLE 3
HEPATIC ARTERY PRESSURES (mm Hg; means + SE)
Time (min)
Group 
(Number of animals)
Pre-
Infusion 0 +3 +15 +30
Controls (5) 65 + 6 64 + 7 63 + 6 61 + 7 6 2 + 6
ETOH + endotoxin (7) 8 0 + 6 74 ± 8 119 + 22 82 + 17 66 + 7
ETOH + endotoxin + ASA 
(7)
82 + 13 79 ±  13 81 + 15 77 + 12 76 + 11
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Figure 11. Determination of Isogravimetric Capillary Pressure 
in a Control Study. The pressure-flow relationship obtained in a control 
(no endotoxin) animal is shown.
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( P c , the venous pressure recorded at a condition of zero flow, was 18i5 
mm Hg in this experiment. A linear relationship is noted between the 
Pc^ and other points. This straight line relationship was previously re­
ported by Johnson ^  al. (1966).
Figure 12 contrasts the pressure-flow relationships obtained in 
a control versus an endotoxin-shocked animal (4 hours after endotoxin). 
Best-fit linear relationships are shown. The control study shows higher 
pressures and flows than the shocked preparation. A Pc^ value of 17 mm Hg 
was exhibited by the control leg while the endotoxin injected limb had a 
Pc^ of only 4 mm Hg. The flat type of curve shown by this shocked pre­
paration was characteristic of all 10 dogs receiving only endotoxin. If 
venous pressures were elevated above the low values shown, steady gains 
in limb weight ensued.
The typical pressure-flow relationship represented in Figure 13 
was obtained in one of the 7 animals given sodium salicylate prior to 
endotoxin. The Pc^ value was 16 mm Hg. The results obtained are very 
similar to those seen in control (no endotoxin) animals. Similar responses 
were observed in the other 6 animals of this treated group.
Figure 14 shows the P c values obtained in all three groups of 
animals. The mean P c value found in control (no endotoxin) dogs was 16 
mm Hg while the mean Pc^ 4 hours after endotoxin was 7 mm Hg. Animals 
receiving ASA pre-treatment failed to demonstrate the lowered Pc^ values 
associated with endotoxin. The mean Pc^ level in preparations given both 
ASA and endotoxin was 16 mm Hg, the same value found in control (no endo­
toxin) studies.
The results found when the pressure-flow relationship was deter­
mined in one of the five dogs at 20 hours postendotoxin are seen in
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Figure 12. Determination of Isogravimetric Capillary Pressure 
in a Control Versus an Endotoxin-Shocked Animal (4 hours postendotoxin), 
The pressure-flow relationships obtained in a control (no endotoxin) 
and in an endotoxin (0.4 mg/kg) injected dog are shown.
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Figure 13. Determination of Isogravimetric Capillary Pressure in 
a Sodium Salicylate and Endotoxin Injection Animal. The pressure-flow 
relationship is presented for an animal given sodium salicylate (80 mg/kg) 
prior to endotoxin (0.4 mg/kg) administration.
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Figure 14. Summary of Isogravimetric Capillary Pressures Obtained 
in Control, Shocked, and Sodium Salicylate Pre-treated Animals. The 
isogravimetric capillary pressure values are shown for fourteen control 
(no endotoxin), ten endotoxin-shocked (0.4 mg/kg), and seven sodium 
salicylate (80 mg/kg) pre-treated dogs. Each line represents the isograv­
imetric capillary pressure value obtained in one experiment.
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Figure 15. Similar results were obtained from the other 4 dogs. The 
Pc^ was lowered as previously noted at 4 hours after endotoxin. It was 
impossible to establish high rates of blood flow in this preparation with­
out inducing a gain in limb weight.
Table 4 summarizes a number of parameters in 15 control experi­
ments and in 17 studies in which endotoxin had been administered 4 hours 
previously. The endotoxin group is divided into 2 series: (1) those
receiving only endotoxin; and (2) those which were pre-treated with sodium 
salicylate followed by endotoxin. The results show that endotoxin signi­
ficantly lowered Pc^, mean systemic arterial pressure (MSAP), pH, and fore­
limb blood flows while significantly elevating hematocrit values. Sodium 
salicylate pre-treatment prevented all of these changes except hemocon- 
centration. It should also be noted that diarrhea was routinely observed 
in endotoxin shocked dogs yet sodium salicylate pre-treatment obliterated 
the diarrhea.
The results obtained 20 hours post-endotoxin are summarized in 
Table 5. Again, there were significant decreases in Pc^ and mean system­
ic arterial pressure. Hematocrit values were increased significantly. 
Forelimb blood flows and pH readings were not altered significantly at 20 
hours after endotoxin. No pre-treated animals were included in the long 
term shock studies.
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Figure 15. Determination of Isogravimetric Capillary Pressure 
in an Endotoxin-Shocked Animal (20 hours postendotoxin). The pressure- 
flow relationship is presented for an animal studied at 20 hours after 
endotoxin injection.
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TABLE 4
EFFECT OF ENDOTOXIN ON DOG PERFUSED FORELIMB WITH 
SPECIAL REFERENCE TO SALICYLATE PRETREATMENT
Experiment
PCi
(mm Hg)
MSAP 
(mm Hg) pH
Hct
(Vol.:
Forelimb 
Blood Flow 
(ml/min per
100 g)
Control, no endotoxin,
N = 15 16+0.6 131+5.2 7.28+0.01 38+1.3 16+1.1
Endotoxin, LDg2
4 Hr. Postendotoxin,
0.4 mg/kg, N = 10 6+0.7
p<0.01
92+10.0
p<0.01
7.13+0.05 
p<0.05
52+1.8
p<0.01
7+1.1
p<0.01
4 Hr. Postendotoxin,
0.4 mg/kg, pre­
treatment with sodium 
salicylate— 80 mg/kg 
N = 7 16+0.5
NS
132+6.4 7.25+0.05 51+1.2 13+1.8
NS NS p<0.01 NS
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TABLE 5
EFFECT OF ENDOTOXIN ON DOG PERFUSED FORELIMB PREPARATION
Forelimb 
Blood Flow
P c M S A P  Hct (ml/min per
Experiment (ram Hg) (mm Hg) pH (Vol.%) 100 g)
Control, no endotoxin, 16+0.6 131+5.2 7.28+0.01 38+1,13 16+1.1
N = 15
20 Hr. postendotoxin, 9+2.2 98+9.3 7.23+0.02 43+2.3 12+4.6
N = 5 p<0.01 p<0.01 NS p = 0.05 NS
CHAPTER IV
DISCUSSION
The results of the present investigations reveal that pre-treatment 
with salicylate obviates many of the pathological responses to endotoxin. 
Acetylsalicylic acid (ASA) can prevent early hemodynamic reactions elicited 
by endotoxin and increase the survival rate. Although the precise mechan­
isms whereby salicylates interrupt the toxic processes are not clearly evi­
dent, several possible explanations are available. Systemic arterial hypo­
tension, characteristically identified with the endotoxin shock state, was 
averted because venous return did not decline. Prevention of the fall in 
venous return was attributed to preclusion of pooling of blood in the liver. 
ASA blocked portal venous and hepatic arterial hypertension. It is import­
ant to note that the agent responsible for prevention of the vascular 
effects of endotoxin shock was ASA and not the buffer solution. Infusion 
of the buffer alone failed to modify the response to endotoxin.
Constriction of the hepatic artery postendotoxin is reportedly due 
to a myogenic response triggered by hepatic venous constriction. Portal 
vein pressure then rises as a passive response to hepatic vein constric­
tion (Hinshaw et al., 1965). Avoidance of portal venous hypertension indi­
cates that ASA acted at the site of the hepatic veins to prevent constric­
tion. It can be speculated that ASA might act in one of the following
ways: (1) directly block the action of endotoxin at the hepatic veins;
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(2) interfere with the action of a vasoactive agent released by the endo­
toxin; or (3) prevent the release of certain humoral agents. Liberation 
of histamine is reportedly accelerated by endotoxin administration 
(Hinshaw et al., 1961a) and histamine elicits portal venous hypertension 
Hinshaw et al., 1962a; Jordan ^  , 1965). The catecholamines have
also been implicated in the elevation of portal vein pressure (Weil and 
Spink, 1957). High levels of plasma serotonin reported in the portal 
vein postendotoxin suggested that serotonin was being released from bowel 
deposits (Davis e_t sd., 1960).
Swyer (1948) was able to show that administration of 100 mg/kg 
body weight of sodium salicylate significantly reduced the effect of 
histamine in rabbits. It has also been reported that salicylates inhibit 
antigen-induced histamine release from guinea pig lung (Mongar and Schild, 
1957). Spector and Willoughby (1963) produced evidence that large system­
ic doses of salicylate suppressed the rat's response to histamine.
Rocha e Silva (1963) showed that salicylate interfered with histamine re­
lease from the isolated rat diaphragm while a communication from Schayer 
(1964) suggested inhibition of the histidine-decarboxylase system. Strom 
and Coffman (1963) found that aspirin attenuated the peripheral circulatory 
response to epinephrine and norepinephrine in human subjects. Vasoconstric­
tion in the human forearm produced by intra-arterial serotonin infusion 
was shown to be inhibited by therapeutic levels of intravenous sodium 
salicylate by Glover and co-workers (1957). The authors considered this 
a specific inhibition of serotonin because they observed no significant 
effect on vasoconstriction produced by intra-arterial norepinephrine or 
histamine. Thus, the reports of Strom and Coffman (1963) and Glover ejt al.
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(1957) seem to be at variance with one another, but the report from 
Glover and co-workers employed intravenous infusions of salicylate while 
Strom and Coffman administered the salicylate orally. A subsequent com­
munication has divulged that aspirin antagonized the vasoconstrictor 
effect of histamine but had no effect upon responses to serotonin in the 
isolated perfused guinea pig lung (Greeff and Moog, 1964). Therefore, it 
is apparent that species differences and route of administration must be 
considered in an evaluation of salicylate action.
During the thirty-minute infusion of ASA to venous return prepara­
tions, an increase in the volume of blood returning to the heart was noted. 
There appear to be several explanations for the increase in venous return. 
Large doses of sodium salicylate reportedly elicit a prompt increase in 
contractile force of the heart (Walton and Darby, 1959). The increase 
in force is short-lived, declining to control levels within 20 minutes 
after completion of salicylate administration. Another reason for an 
augmented cardiac output may be an indirect result of profound metabolic 
stimulation. The increase in metabolic rate is effected by uncoupling 
of oxidative phosphorylation (Smith, 1966b). A two-fold increase in oxy­
gen consumption was found when large doses of sodium salicylate were ad­
ministered to anesthetized dogs (Tenney and Miller, 1955). The source of 
the previously mentioned increase in metabolism was found to be skeletal 
muscle. The authors concluded that the circulatory system met the in­
creased level of oxygen consumption by widening the auriculoventricular 
oxygen difference and increasing cardiac output (Tenney and Miller, 1955). 
A third reason for a rise in the venous return is thought to be the stim­
ulation of the pituitary-adrenal system (Done eb £l., 1958). This could
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cause a contraction of the spleen and emptying of the hepatic bed, 
effecting an increase in blood returning to the heart.
Salicylate pre-treatment obliterated the acidosis frequently found 
in endotoxin-shocked dogs. Hyperventilation, promoted directly by stim­
ulation of the respiratory center and indirectly by the increased meta­
bolic production of carbon dioxide (Tenny and Miller, 1955) may account 
for prevention of a drop in pH levels. Large doses of salicylates thus 
produce a primary hyperventilation with lowering of the carbon dioxide 
tension in the blood leading to an alkalotic tendency. Respiratory stim­
ulation has been found with massive salicylate administration in dogs 
(Boyle ^  al., 1947; Tenney and Miller, 1955) and in humans (Ghose, 1967).
The final phase of this research endeavor was aimed at investiga­
tion of the mechanism of fluid loss in endotoxin shock. The capillary 
bed of an isolated perfused forelimb of the dog was chosen as the research 
model. The results obtained suggest that endotoxin administration modified 
certain properties of the capillary membrane. The isogravimetric capillary 
pressure, defined as the highest capillary hydrostatic pressure at which 
edema formation (gain in leg weight) does not occur, was significantly 
lowered by 4 hours after endotoxin injection.
The technique utilized to obtain isogravimetric capillary pressures 
(Pcj_) was originally described by Pappenheimer and Soto-Rivera (1948) and 
later modified by Johnson and co-workers (1966). The Pc^ values obtained 
in control (no endotoxin) animals in this study (16 mm Hg) are in close 
agreement with those values reported by Pappenheimer and Soto-Rivera (1948) 
utilizing an extrapolation to zero flow to get Pc^ levels (17 mm Hg). 
Johnson et al. (1966) extended the technique to include direct measurement
85
of Pc^ at conditions of zero flow. The present study employed the 
zero flow method and obtained Pc^ results (16 mm Hg) very similar to 
those reported by Johnson and co-workers in 1966 (15 mm Hg). In contrast 
to the mean value of 16 ram Hg seen in control (no endotoxin) animals, a 
mean-Pc^ value of 7 mm Hg was observed in endotoxin-shocked dogs. Since 
the capillary bed of the forelimb was unable to support the higher levels 
of pressure seen in control dogs, it appeared that capillary permeability 
had been increased. Any attempt to raise the pressure in shocked prepara­
tions elicited an extravasation of fluid, as evidenced by a gain in weight.
Some of the changes seen in the forelimb postendotoxin might be 
attributed to the 4 hour period of ischemia. The limb was autoperfused 
by the endotoxin-shocked dog for 4 hours prior to perfusion with the 
pump. Since cardiac output and systemic arterial pressure fell to shock 
levels, it is reasonable to assume that blood flow to the leg was diminish­
ed. This condition of low flow rate could have permitted accumulation of
metabolites which may have effected changes in the limb capillary bed.
An evaluation of the method employed to ascertain extravasation 
and absorption of fluid is pertinent to this discussion. The criterion
for extravasation of fluid is an increase in limb weight. Conversely,
a decline in limb weight is said to signify absorption of fluid from 
tissue spaces into the capillary vessels. The previous papers describing 
this experimental technique (Pappenheimer and Soto-Rivera, 1948; Johnson 
et , 1966) and the present investigation provide no direct evidence 
that a weight gain actually represents loss of vascular fluid to tissue 
spaces and not the filling of empty intravascular capillary spaces. The 
validity of the results obtained using this investigative technique depend
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on the assumption that an increase in weight of the perfused limb is 
equated with extravasation of vascular fluid. The best evidence support­
ing this assumption comes from work by Johnson and Hanson (1962) in which 
protein concentrations were measured simultaneously on the arterial and 
venous sides of the capillary bed being examined. The authors reported 
increases in venous protein concentrations which were correlated with 
increases in weight. The elevation in venous protein levels was ascribed 
to a loss of plasma water to extravascular spaces.
The Starling hypothesis (Starling, 1896) describing transcapillary 
fluid exchange, is helpful in evaluating the results obtained in the limb 
perfusion study. The Starling hypothesis delineates three factors in­
volved in transcapillary fluid exchange: (1) the differences in hydro­
static pressure across the capillary membrane; (2) protein osmotic pres­
sures acting within the vascular bed and in the extravascular compartment; 
and (3) the properties of the capillary membrane which influence fluid 
transfer from intravascular to extravascular regions. The hydrostatic 
pressure across the membrane was zero when Pc^ values were determined 
in this study. A report that plasma protein concentrations were at normal 
levels 4 hours postendotoxin (Chien e^ al., 1966) suggests that the second 
factor of the Starling hypothesis is not involved in the alteration of the 
capillary bed. Thus it appears that endotoxin administration modifies 
certain physical properties of the capillary membrane. It can only be 
speculated as to whether this is the result of a direct action of the 
endotoxin on the capillary membrane or due to action of vasoactive agents 
released by endotoxin administration. The failure of isolated organs per­
fused by a pump-lung apparatus (Hinshaw et al., 1962b) to respond to
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endotoxin tends to implicate released neurohumoral agents.
Venous constriction, previously reported in the forelimb (Hinshaw 
£t £l., 1962b), would tend to elevate capillary pressures, thus promoting 
extravasation of plasma fluid. Small vein constriction postendotoxin did 
not appear to interfere with estimation of Pc^, since at zero flow, vas­
cular constriction would have no influence on the value of isogravimetric 
capillary pressure. Conversely, venous dilatation would not interfere 
with this technique as suggested in a report that sympatholytic agents did 
not appreciably alter Pc^ levels, although postcapillary resistance de­
clined (Hanson and Johnson, 1962).
Administration of sodium salicylate prevented the decrease in 
Pc^ levels. Pre-treated dogs revealed a mean Pc^ value of 16 mm Hg at 
4 hours after endotoxin, the same mean value obtained in control studies. 
The salicylates may act by directly stabilizing the walls of the micro­
circulation, or may interfere with the release or antagonize the action 
of vasoactive substances released by endotoxin. An interference with the 
release of histamine from mast cells (Rocha e Silva, 1963) or action of 
histamine (Spector and Willoughby, 1963) is possible. There are reports 
that toxic vascular changes are partly due to destruction of vasocon­
strictor amines which would otherwise constrict and reduce permeability, 
hence opposing the action of histamine and kinins (Cameron and Spector, 
1961). It has been suggested that salicylates interfere with sympatho­
mimetic amine destruction (Smith, 1966a). Endotoxin may also cause the 
release of kinins (Nies £_t , 1968). It appears that histamine is
only active in the early response to toxin and that other factors, such 
as kinins, are responsible for the acute inflammatory response (Smith,
1966a). Work by Spector and Willoughby (1963) and Northover and Sub- 
raraanian (1961) suggests that salicylates inhibit the activity of the 
plasma kinin-forming enzymes, thus preventing the release of kinins.
Bhoola and collaborators (1962) reported that aspirin antagonized in­
jected bradykinin. Slow reacting substance-A (SRS-A), a substance often 
released in anaphylactic reactions and associated with edema formation is 
also reportedly antagonized by salicylates (Collier, 1962). The most de­
finite statement that can be made about the action of salicylates is 
that they are able to stabilize capillary permeability in the face of 
endotoxin administration.
In conclusion, several critical evaluations of the data presented 
here are appropriate. This research has centered only on the response of 
the dog to endotoxin. It has been clearly established that many differ­
ences occur in the species response to endotoxin (Kuida, 1961; Guenter 
e_t ^ . , 1969). Therefore, application of the canine response to other 
species, especially the primates, should be carefully examined. The 
majority of the experimental techniques employed here were very traumatic 
to the animal. Thus, experiments were carried out on anesthetized ab­
normal animals. Swan and Jacobson (1967) have shown that the hemodynamic 
response of the conscious animal varies from that of the anesthetized dog. 
This does not necessarily invalidate the results because all experiments 
were controlled and all results were compared only to the control (no 
endotoxin) studies. Recent reports have suggested that the response to 
endotoxin injection may vary from the response to a Gram-negative septi­
cemia (Waisbren, 1964; Hinshaw _et , 1968). This would indicate that 
the experimental administration of purified endotoxin to an anesthetized
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dog might be at great variance with the response seen in a patient with 
a Gram-negative infection. More studies are required in which the primate 
is the shock model and live organisms are used in place of endotoxin.
CHAPTER V
SUMMARY
This dissertation has presented an evaluation of the hemodynamic 
responses to endotoxin. The laboratory shock model employed was the anes­
thetized mongrel dog. Salicylates were utilized to modify the response to 
Gram-negative toxin in an attempt to elucidate some of the basic mechan­
isms operating during the shock state. The basic goal was determination 
of how salicylates act to prevent pathogenesis of the shock state. Bene­
ficial actions were found in the capillary and post-capillary vascular 
areas.
The acute response of the anesthetized dog to a lethal dose of 
endotoxin is characterized by systemic arterial hypotension, sequestration 
of blood in the liver and diminished venous return accompanied by acidosis 
and hemoconcentration. Infusion of large doses of buffered ASA, prior to 
administration of the endotoxin, obliterated the usual shock-like state: 
(1) systemic arterial pressure remained significantly elevated; (2) portal 
hypertension did not occur; (3) venous return was maintained at normal 
levels; and (4) acidosis was prevented. Ablation of the decrease in card­
iac output and systemic arterial pressure was attributed primarily to 
prevention of hepatic pooling. Stimulation of the myocardium, resulting 
in a short-term enhancement of contractile force, may also have aided in 
maintaining a normal state in the circulatory system. Respiratory
90
91
stimulation, attributed to the salicylates, probably reversed the acidotic 
tendency. Administration of buffered ASA 15 minutes after injection of the 
toxin resulted in restoration of systemic arterial pressure and pH values. 
Pre-treatment with buffered and unbuffered ASA prior to endotoxin adminis­
tration significantly increased the survival rate over the untreated endo­
toxin-shocked group of animals. The results obtained suggested that the 
lethal effects of endotoxin are related to its hemodynamic alterations.
Experiments were performed on i^ . situ liver perfusions with con­
trolled hepatic arterial and portal venous flows. Intravenous injections 
of ASA prior to administration of endotoxin prevented the constriction 
observed in both the hepatic artery and hepatic vein of animals receiving 
only endotoxin. It was suggested that ASA was acting in one of the follow­
ing ways: (1) at the site of the hepatic veins to reverse the constrictor
effects of endotoxin or vasoactive agents, such as histamine, released by 
endotoxin or (2) preventing the release of humoral agents capable of elic­
iting venous constriction.
An evaluation of the canine forelimb capillary bed indicated that 
endotoxin promotes an increase in capillary permeability. Isogravimetric 
capillary pressures obtained in endotoxin-shocked preparations were signi­
ficantly lower than those found in control (no endotoxin) studies. That 
is, the capillary bed of shocked animals was unable to support the higher 
pressures seen in control dogs. It has been suggested that fluid loss 
due to increased permeability of the capillary system might be at least 
partially responsible for the late phase of decreased venous return seen 
during endotoxin shock. The apparent increase in permeability is thought 
to be due to a direct action of endotoxin or released vasoactive agents
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on the capillary membrane. Sodium salicylate pre-treatment averted the 
permeability changes associated with endotoxin administration. The sali­
cylates are said to stabilize the capillary membrane.
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